ESCMID eLibrary
Search results
Icon explanation
Icon explanation
close
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
Found 9 results
-
P1724
Conceptual framework for the design of individualized anti-infective impregnated bone cement : a voriconazole example
25 April 2017
Session: Antifungal drugs and treatment II
Relevance:100%
-
P1186
Pharmacokinetic and pharmacodynamic evaluation of vancomycin for the prophylaxis of surgical site infections in morbidly obese patients
24 April 2017
Session: PK/PD studies in humans
Relevance:100%
-
P1724
Intracytoplasmic compartment of host cells: a bacterial reservoir for vancomycin-intermediate Staphylococcus aureus isolates
12 April 2016
Session: Staphylococcal pathogenesis
Relevance:100%
-
P1186
Characterization of a novel variant of KPC with decreased susceptibility to phenylboronic acid
11 April 2016
Session: Deciphering carbapenem resistance
Relevance:100% -
P1389
Application of drug interaction modelling and Monte Carlo simulation to predict the potential killing effect of combination antimicrobial treatment regimens in humans
28 April 2015
Session: PK/PD studies
Relevance:100%
-
P1746
Use of Bayesian pharmacokinetic models to predict meropenem concentrations in critically ill patients – application to therapeutic drug monitoring
13 May 2014
Session: PK/PD of antibiotics against Gram-negatives
Relevance:100%
-
P1666
Development of a smartphone application prototype to individualise antibiotic dosing in critically ill patients based on the results of population-pharmacokinetic models and Monte Carlo simulations
28 April 2013
Session: Internet and electronic resources
Relevance:100%
-
P898
Pharmacodynamic profiling of prolonged infusion of ertapenem in critically-ill patients with early-onset ventilator-associated pneumonia through the use of a population pharmacokinetic model and Monte Carlo simulation
27 April 2013
Session: PK/PD of beta-lactams and glycopeptides
Relevance:100%
-
P934
Model-based optimisation of daptomycin dosing during high-intensity renal replacement therapy
27 April 2013
Session: PK/PD: new drugs, the critically and resistant bugs
Relevance:100%
